AB

Adaptive Biotechnologies

ADPT
NASDAQHealth Care

Income Statement

Total Revenue$178.96M
Gross Profit$106.88M
Operating Income$-162.55M
EBITDA$-123.38M
EBIT$-147.91M
Pre-tax Income$-59.46M
Net Income$-159.49M

Balance Sheet

Cash Equivalent$57.22M
Total Debt$225.37M
Book Value$235.56M
Book Value Per Share1.60

Key Ratios

Return on Equity (ROE)-78.68%
Return on Assets (ROA)-29.57%
Return on Invested Capital (ROI)-47.47%
Net Profit Margin-89.12%
Current Ratio2.89
Quick Ratio2.71
Long-Term Debt / Equity0.65